Practice Areas
- Defective Medical Products
- Guidant Class Action Lawsuit
- DePuy Hip Replacement Lawsuit
- Hip Replacement Recall
- Lawyer for DePuy Lawsuit Minneapolis, Minnesota
- Hip Replacement Lawyer Minneapolis, MN
- Compounding Pharmacy Error
- DePuy Lawsuit
- Hip Replacement Lawsuit
- Hip Replacement Lawyer
- Hip Replacement Recall Lawsuit
- Hip Revision Surgery Lawsuit
- Hip Revision Surgery Lawyer
- Johnson & Johnson Hip Class Action Lawsuit
- Lawsuit against DePuy for Hip Revision Surgery
- Visicol Kidney Failure
- Visicol Lawsuit
- OsmoPrep Lawsuit
- Acute Phosphate Nephropathy
- Yasmin Lawsuit
- Yasmin Class Action Lawsuit
- Yaz Lawsuit
- Class Action Lawsuit Yaz
- Hip Replacement Lawyer Minneapolis, MN
- Lawyer for DePuy Lawsuit Minneapolis, MN
- FDA Recalls
- News & Topics
Other Practice Areas
- E coli Poisoning
- Hemolytic Uremic Syndrome (HUS)
- Campylobacter
- Clostridium Perfringens
- Hemolytic Uremic Syndrome (HUS)
- Hepatitis A Food Poisoning
- Listeria Poisoning
- Listeriosis
- Salmonella Lawyer
- Shigella
- Amputation
- Burn Attorney
- Spinal Cord Injury
- Traumatic Brain Injury
- Wrongful Death
- Minnesota Car Accident Attorney
- Defective Products
- Foodborne Illness
- Medical Malpractice
- MN Accident Attorney
- Minnesota Dog Bite Attorney
- Minnesota Injury Lawyer
- Semi Truck Accident Lawyer MN
- Child Safety Lawyers
Personal Injury and Wrongful Death
MEDTRONIC DEFIBRILLATOR LEAD RECALL: MEDTRONIC RECALL INFORMATION
We are not taking these cases. The information below is as a public service.
Medtronic Recall
Medtronic has removed its Sprint Fidelis defibrillator leads from the market because they may fracture, which can cause the defibrillator to deliver unnecessary shocks or not operate at all. This is considered a Medtronic recall. Some deaths, at least 13, and major complications have occurred after the leads have fractured (Medtronic is reporting 13 deaths, but at least 46 deaths have been alleged to be associated with a Medtronic Sprint Fidelis defibrillator lead.)
A defibrillator lead connects the defibrillator, which is implanted near the shoulder, to the heart. If a lead fractures, it may send false signals to the defibrillator, causing the defibrillator to deliver unnecessary shocks or, in some cases, not to pace or shock when needed. Our clients have explained that the shocks are quite painful and that the fear of experiencing additional shocks is intense.
More than 268,000 recalled Medtronic leads were used with various defibrillators. Patients should consult their doctors regarding their defibrillator leads, and if a Sprint Fidelis defibrillator lead is involved, they should discuss what course of action to take.
The FDA has provided the following explanation of the defect and recommendations regarding the Sprint Fidelis defibrillator leads:
Implantable cardioverter defibrillators (ICDs) and Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) are used to treat abnormal heart rhythms that can cause the heart to stop suddenly. ICDs and CRT-Ds shock the heart back into normal rhythm by sending a pulse of energy through an electronic wire or lead that is connected to the heart.
When a defibrillator lead is slightly more prone to fracture, it doesn't mean that every lead will break. Most leads will function well, as is the case with Sprint Fidelis. In the infrequent circumstance where a lead actually breaks, or "fractures," the lead may send false signals that cause inappropriate defibrillator shocks, or therapies such as pacing or shocks may not be delivered.
Current adverse event information indicates that fractures have occurred in less than 1 percent of the approximately 268,000 of these leads implanted worldwide. We don't know if this rate of adverse events will remain constant or increase over the life of these leads.
FDA considers Medtronic's action to be a product recall, as defined by FDA regulations, and we will soon be issuing a recall classification for this action. We recognize that some patients and health care professionals might inappropriately interpret the word "recall" to mean that the devices must be surgically removed and returned to the manufacturer. Although the leads should no longer be implanted in patients, we do not mean to imply that these leads should be surgically removed.
The leads continue to function properly in the vast proportion of patients. Although there is no test to predict which lead will fracture, FDA agrees with Medtronic's recommendation that defibrillator settings be adjusted at the patient's next scheduled follow-up visit with their doctor. Doing so may increase the likelihood that a fracture will be detected before a patient is harmed.
Neither FDA, Medtronic, nor representatives of the Heart Rhythm Society, recommend the routine surgical removal of a fractured lead because removal carries risks. Instead, physicians should weigh the benefits and risks of either continuing to use the lead with careful monitoring or capping the lead so it is no longer useable and implanting a different model.
Patients should recognize that a small number of Sprint Fidelis leads are used with defibrillators made by manufacturers other than Medtronic. If patients have reason to believe that they have a Sprint Fidelis lead or if they do not know the model of their lead, they should contact their health care professional.
FDA will continue to monitor information on these devices and will take whatever other actions may be necessary.
Free Case Consultation
We are Not Paid Unless You Win
Our attorneys work on a continguency fee basis, meaning you do not have to pay our law firm for representing you unless we win you money.
Firm News
AV Preeminent Rating by Martindale-Hubbell
![]()
Attorneys Fred Pritzker and Eric Hageman have been given the highest rating by Martindale-Hubbell for attorney, AV Preeminent. An AV® certification mark is a significant rating accomplishment - a testament to the fact that a lawyer's peers rank him or her at the highest level of professional excellence.
Adjunct Teaching Position At U of M Law School
Attorney Brendan Flaherty has accepted an adjunct teaching position at the University of Minnesota Law School. For the 2011 spring semester, Flaherty will teach a course entitled "Practice and Professionalism," which will introduce students to foundational lawyering skills and professional responsibility issues.
Attorney Elliot Olsen Speaks at Conference
Attorney Elliot Olsen recently spoke at the Seventh Annual LifeScience Alley Conference in Minneapolis on Preemption and the Future of Medical Device Litigation. He appeared with Randall Pattee of Lindquist and Vennum and Jean Lance, VP of corporate legal and general counsel for Boston Scientific.
Named Super Lawyer
In recognition of their
achievements, Attorneys Fred Pritzker, Elliot Olsen and Eric Hageman were named "Super Lawyers" by Law & Politics magazine. According to Super Lawyers, "The objective is to create a credible, comprehensive and diverse listing of outstanding attorneys that can be used as a resource to assist attorneys and consumers in the search for legal counsel."
Brendan Flaherty Named a Rising Star
In recognition of his achievements, Attorney Brendan Flaherty was named a 2010 Rising Star by Minnesota Law & Politics. Only 2.5 percent of the state’s lawyers are included on the list, which highlights Minnesota’s best up-and-coming legal talent.
Fred Pritzker Listed in The Best Lawyers in America
Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.
This is attorney advertising. Past results do not guarantee a similar outcome. The result of each case is determined by the specific facts and the applicable law.

